Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert D'Haens

Showing results (231-240 of 269) with videos related to

Pageof 27
Sort By:
Journal of Crohn'S & Colitis|December 19, 2023
Outcomes and Endpoints of Postoperative Recurrence in Crohn's Disease: Systematic Review and Consensus ConferenceNassim Hammoudi, David Sachar, Geert D'Haens, et al.
JCI Insight|February 9, 2026
Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomesSteve De Vos, Nicolas Desroy, Susan J Bellaire, et al.
The Lancet. Gastroenterology & Hepatology|January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trialEdouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Inflammatory Bowel Diseases|August 21, 2010
IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meetingDaniel C Baumgart, Charles N Bernstein, Zaigham Abbas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2018
Efficacy of Endoscopic Dilation of Gastroduodenal Crohn's Disease Strictures: A Systematic Review and Meta-Analysis of Individual Patient DataDominik Bettenworth, Marcus M Mücke, Rocio Lopez, et al.
The Lancet. Gastroenterology & Hepatology|April 5, 2025
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial designSailish Honap, Nelly Agrinier, Joana Torres, et al.
Digestive Diseases and Sciences|June 11, 2009
Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patientsMartin H Holtmann, Frank Krummenauer, Christina Claas, et al.
Lancet (London, England)|June 1, 2022
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trialsSilvio Danese, Séverine Vermeire, Wen Zhou, et al.
Gut|October 18, 2015
Development and validation of a histological index for UCMahmoud H Mosli, Brian G Feagan, Guangyong Zou, et al.
Digestive Diseases and Sciences|August 24, 2006
Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patientsMartin H Holtmann, Frank Krummenauer, Christina Claas, et al.
Pageof 27

Showing results (231-240 of 269) with videos related to

Sort By:
Pageof 27
Journal of Crohn'S & Colitis|December 19, 2023
Outcomes and Endpoints of Postoperative Recurrence in Crohn's Disease: Systematic Review and Consensus ConferenceNassim Hammoudi, David Sachar, Geert D'Haens, et al.
JCI Insight|February 9, 2026
Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomesSteve De Vos, Nicolas Desroy, Susan J Bellaire, et al.
The Lancet. Gastroenterology & Hepatology|January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trialEdouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Inflammatory Bowel Diseases|August 21, 2010
IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meetingDaniel C Baumgart, Charles N Bernstein, Zaigham Abbas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2018
Efficacy of Endoscopic Dilation of Gastroduodenal Crohn's Disease Strictures: A Systematic Review and Meta-Analysis of Individual Patient DataDominik Bettenworth, Marcus M Mücke, Rocio Lopez, et al.
The Lancet. Gastroenterology & Hepatology|April 5, 2025
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial designSailish Honap, Nelly Agrinier, Joana Torres, et al.
Digestive Diseases and Sciences|June 11, 2009
Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patientsMartin H Holtmann, Frank Krummenauer, Christina Claas, et al.
Lancet (London, England)|June 1, 2022
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trialsSilvio Danese, Séverine Vermeire, Wen Zhou, et al.
Gut|October 18, 2015
Development and validation of a histological index for UCMahmoud H Mosli, Brian G Feagan, Guangyong Zou, et al.
Digestive Diseases and Sciences|August 24, 2006
Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patientsMartin H Holtmann, Frank Krummenauer, Christina Claas, et al.
Pageof 27